What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Fungus
Michael G. Rinaldi mostly deals with Microbiology, Fluconazole, Mycosis, Amphotericin B and Itraconazole.
His study in Voriconazole, Minimum inhibitory concentration, Broth microdilution, Posaconazole and Aspergillus is done as part of Microbiology.
The concepts of his Fluconazole study are interwoven with issues in Azole and Candida albicans.
His Mycosis research includes themes of Pathology, Internal medicine, In vitro and Virology.
His Amphotericin B study combines topics in areas such as Trichosporon beigelii, Chromatography, Fungi imperfecti and Aspergillus terreus.
His studies deal with areas such as Antibiotics, Etest, Pseudallescheria boydii, Ketoconazole and Pharmacology as well as Itraconazole.
His most cited work include:
- Transcatheter Mitral-Valve Repair in Patients with Heart Failure (884 citations)
- Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole (831 citations)
- RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE (787 citations)
What are the main themes of his work throughout his whole career to date?
Michael G. Rinaldi mainly focuses on Microbiology, Mycosis, Fluconazole, Amphotericin B and Internal medicine.
His biological study spans a wide range of topics, including Dermatology, Pathology, Phaeohyphomycosis and Chemotherapy.
His work deals with themes such as Viral disease, Candida glabrata, Candida albicans and Virology, which intersect with Fluconazole.
His Amphotericin B study incorporates themes from Aspergillus fumigatus, Itraconazole, Antibiotics and Aspergillosis.
His work focuses on many connections between Itraconazole and other disciplines, such as Pharmacology, that overlap with his field of interest in In vivo and In vitro.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery and Cardiology.
He most often published in these fields:
- Microbiology (52.34%)
- Mycosis (36.72%)
- Fluconazole (34.64%)
What were the highlights of his more recent work (between 2007-2021)?
- Internal medicine (21.87%)
- Cardiology (7.81%)
- Microbiology (52.34%)
In recent papers he was focusing on the following fields of study:
Michael G. Rinaldi mainly investigates Internal medicine, Cardiology, Microbiology, Platelet reactivity and Mitral regurgitation.
The Internal medicine study combines topics in areas such as Gastroenterology and Drug.
His work is connected to Posaconazole, Broth microdilution, Voriconazole, Amphotericin B and Caspofungin, as a part of Microbiology.
His Posaconazole study combines topics from a wide range of disciplines, such as In vitro and Pharmacology.
His Voriconazole research is multidisciplinary, incorporating elements of Itraconazole and Aspergillosis.
Amphotericin B and Immunology are commonly linked in his work.
Between 2007 and 2021, his most popular works were:
- Transcatheter Mitral-Valve Repair in Patients with Heart Failure (884 citations)
- Infections Caused by Scedosporium spp. (498 citations)
- MOLECULAR PHYLOGENETIC DIVERSITY, MULTILOCUS HAPLOTYPE NOMENCLATURE, AND IN VITRO ANTIFUNGAL RESISTANCE WITHIN THE FUSARIUM SOLANI SPECIES COMPLEX (290 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Fungus
His primary areas of study are Microbiology, Posaconazole, Internal transcribed spacer, Genetics and Fungi imperfecti.
In his research on the topic of Microbiology, Mucor velutinosus is strongly related with Mucorales.
The various areas that Michael G. Rinaldi examines in his Posaconazole study include In vitro, Aspergillosis, Pharmacology and Virology.
His studies in Voriconazole integrate themes in fields like Flucytosine, Itraconazole, Drug resistance and Candida krusei.
His Drug resistance research is multidisciplinary, relying on both Aspergillus, Aspergillus fumigatus, Minimum inhibitory concentration, Mycosis and Candida spp.
His research integrates issues of Trichosporon mycotoxinivorans, Pneumonia, Cystic fibrosis, Pathology and Sputum in his study of Amphotericin B.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
